Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density | Zendy

Christopher C. Riedl | Zendy; Nikolaus Luft | Zendy; Clemens Bernhart | Zendy; Michael Weber | Zendy; Maria Bernathova | Zendy; MuyKheng M. Tea | Zendy; Margaretha Rudas | Zendy; Christian F. Singer | Zendy; Thomas H. Helbich | Zendy

Open Access

Triple-Modality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density

Author(s) -

Christopher C. Riedl,

Nikolaus Luft,

Clemens Bernhart,

Michael Weber,

Maria Bernathova,

MuyKheng M. Tea,

Margaretha Rudas,

Christian F. Singer,

Thomas H. Helbich

Publication year - 2015

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2014.56.8626

Subject(s) - medicine , mammography , breast cancer , magnetic resonance imaging , radiology , ultrasound , breast mri , population , cancer , oncology , environmental health

To evaluate the breast cancer screening efficacy of mammography, ultrasound, and magnetic resonance imaging (MRI) in a high-risk population and in various population subgroups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research